D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 99 Citations 27,509 306 World Ranking 3962 National Ranking 173

Overview

What is he best known for?

The fields of study he is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Public health

Mark W. Tyndall mostly deals with Substance abuse, Cohort, Acquired immunodeficiency syndrome, Cohort study and SAFER. His Substance abuse study combines topics from a wide range of disciplines, such as Odds ratio, Surgery, Psychological intervention and Drug. The various areas that Mark W. Tyndall examines in his Cohort study include Condom, Psychiatry, Heroin and Emergency medicine.

His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating elements of Demography, Immunology, Internal medicine, Risk factor and Hazard ratio. In Cohort study, Mark W. Tyndall works on issues like Methadone, which are connected to Speedball and Polysubstance dependence. His biological study spans a wide range of topics, including Social policy, Environmental health, Medical emergency, Social work and Public health.

His most cited work include:

  • Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review (1048 citations)
  • The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic (455 citations)
  • Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work (383 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cohort, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Public health. His Cohort research is multidisciplinary, relying on both Odds ratio, Surgery, Hepatitis C virus, Hepatitis C and Hepatitis. His studies deal with areas such as Demography, Epidemiology and Risk factor as well as Acquired immunodeficiency syndrome.

His Cohort study research includes themes of Prospective cohort study and Substance abuse. His work in Substance abuse addresses issues such as Drug, which are connected to fields such as Syringe. His work carried out in the field of Public health brings together such families of science as Psychiatry, Family medicine and Environmental health.

He most often published in these fields:

  • Cohort (36.13%)
  • Internal medicine (29.19%)
  • Acquired immunodeficiency syndrome (25.72%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cohort (36.13%)
  • Hepatitis C (17.63%)
  • Internal medicine (29.19%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cohort, Hepatitis C, Internal medicine, Hepatitis and Hepatitis C virus. His work deals with themes such as Demography, Medical prescription, Prescription drug, Large population and Direct acting, which intersect with Cohort. Demography and Public health are commonly linked in his work.

His Hepatitis C study integrates concerns from other disciplines, such as Coinfection, Hepatitis B and Cohort study. Mark W. Tyndall interconnects Ledipasvir, Oncology and Sofosbuvir in the investigation of issues within Internal medicine. His Hepatitis research integrates issues from Epidemiology, Incidence, Lower risk, Hazard ratio and Pediatrics.

Between 2015 and 2021, his most popular works were:

  • Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis (85 citations)
  • The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC) (64 citations)
  • Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. (63 citations)

In his most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Law

His primary areas of study are Hepatitis C, Cohort, Hepatitis, Public health and Hepatitis C virus. The study incorporates disciplines such as Immunology, Medical prescription and Cohort study in addition to Cohort. His studies examine the connections between Cohort study and genetics, as well as such issues in Lower risk, with regards to Substance abuse, Proportional hazards model and Hazard ratio.

His study in Hepatitis is interdisciplinary in nature, drawing from both Hepatitis B and Epidemiology. His research integrates issues of Psychiatry and MEDLINE in his study of Public health. His Internal medicine research incorporates themes from Gastroenterology and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

Bradley M Mathers;Louisa Degenhardt;Louisa Degenhardt;Benjamin Phillips;Lucas Wiessing.
The Lancet (2008)

1553 Citations

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)

652 Citations

Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work

Kate Shannon;Thomas Kerr;Shari Allinott;Jill Chettiar.
Social Science & Medicine (2008)

536 Citations

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.

Mark W Tyndall;Sue Currie;Patricia Spittal;Kathy Li.
AIDS (2003)

436 Citations

Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers.

Kate Shannon;Thomas Kerr;Steffanie A. Strathdee;Jean Shoveller.
BMJ (2009)

351 Citations

Structural and Environmental Barriers to Condom Use Negotiation With Clients Among Female Sex Workers: Implications for HIV-Prevention Strategies and Policy

Kate Shannon;Steffanie A. Strathdee;Jean Shoveller;Melanie Rusch.
American Journal of Public Health (2009)

342 Citations

Safer injection facility use and syringe sharing in injection drug users

Thomas Kerr;Thomas Kerr;Mark Tyndall;Mark Tyndall;Kathy Li;Kathy Li;Julio Montaner;Julio Montaner.
The Lancet (2005)

327 Citations

Hospital utilization and costs in a cohort of injection drug users

Anita Palepu;Mark W. Tyndall;Hector Leon;Jennifer Muller.
Canadian Medical Association Journal (2001)

309 Citations

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users

Evan Wood;Thomas Kerr;Will Small;Kathy Li.
Canadian Medical Association Journal (2004)

305 Citations

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

David M. Patrick;Mark W. Tyndall;Peter G.A. Cornelisse;Kathy Li.
Canadian Medical Association Journal (2001)

286 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark W. Tyndall

Thomas Kerr

Thomas Kerr

University of British Columbia

Publications: 635

Evan Wood

Evan Wood

University of British Columbia

Publications: 551

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 474

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 228

Steffanie A. Strathdee

Steffanie A. Strathdee

University of California, San Diego

Publications: 191

Kate Shannon

Kate Shannon

University of British Columbia

Publications: 155

Benedikt Fischer

Benedikt Fischer

Federal University of Sao Paulo

Publications: 134

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 123

Marina B. Klein

Marina B. Klein

McGill University Health Centre

Publications: 113

Louisa Degenhardt

Louisa Degenhardt

University of New South Wales

Publications: 109

Will Small

Will Small

Simon Fraser University

Publications: 108

Don C. Des Jarlais

Don C. Des Jarlais

New York University

Publications: 103

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 103

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 99

Frederick L. Altice

Frederick L. Altice

Yale University

Publications: 99

Lisa Maher

Lisa Maher

University of New South Wales

Publications: 97

Trending Scientists

Jonathan Berant

Jonathan Berant

Tel Aviv University

Bernard De Baets

Bernard De Baets

Ghent University

Ke-Qing Xia

Ke-Qing Xia

Southern University of Science and Technology

William R. Young

William R. Young

Brunel University London

Gerald V. Gibbs

Gerald V. Gibbs

Virginia Tech

Corbin D. Jones

Corbin D. Jones

University of North Carolina at Chapel Hill

Wim de Vries

Wim de Vries

Wageningen University & Research

Patrick C. H. Morel

Patrick C. H. Morel

Massey University

Adrian Leuchtmann

Adrian Leuchtmann

ETH Zurich

Cheri Ostroff

Cheri Ostroff

University of South Australia

Julio A. Panza

Julio A. Panza

New York Medical College

Satu Männistö

Satu Männistö

Finnish Institute for Health and Welfare

Meng-Chao Wu

Meng-Chao Wu

Second Military Medical University

Thomas M. Ulbright

Thomas M. Ulbright

Indiana University

Joan Cunningham

Joan Cunningham

Charles Darwin University

Peter Woods

Peter Woods

The Open University

Something went wrong. Please try again later.